Recent Updates
Recently added Catalysts
LFWD Positive Sentiment Score: 70/100

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

Key Takeaway: Lifeward Ltd. has announced that it will release its first quarter 2025 financial results on May 15, 2025. The announcement includes details of a conference call where the CEO and CFO will discuss the results. Lifeward is recognized for its innovative products aimed at improving the lives of individuals with physical limitations and operates in multiple countries, including the U.S., Israel, and Germany.

Market Sentiment Analysis

POSITIVE FACTORS

  • Lifeward is a leader in innovative medical technology.
  • The upcoming financial results could reflect positive growth.
  • The company is committed to advancing solutions that benefit people with disabilities.

Full Press Release Details

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a  global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its first quarter 2025 financial results before the markets open on Thursday, May 15, 2025.
Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EDT to discuss the financial results. To access the call, analysts and investors may utilize the following:
Toll free (U.S.) 1-833-316-0561
International (U.S) 1-412-317-0690
Germany 0800-6647650
Israel 1-80-9212373
Access Code Please reference the “Lifeward Earnings Call”
The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/5e35v6wk. An archived webcast will also be available on the company's website.
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Lifeward Media Relations:
Vice President, Marketing & New Business Development
Lifeward Investor Contact:
Chief Financial Officer

Frequently Asked Questions

When will Lifeward announce its Q1 2025 financial results?

Lifeward will release its Q1 2025 financial results on May 15, 2025.

How can I access Lifeward's earnings call?

Access the earnings call by calling 1-833-316-0561 for U.S. callers or via the webcast.

What innovative products does Lifeward offer?

Lifeward offers the ReWalk Exoskeleton, AlterG Anti-Gravity system, MyoCycle FES, and ReStore Exo-Suit.

Where is Lifeward headquartered?

Lifeward is based in Marlborough, Massachusetts, with operations in Israel and Germany.

What is Lifeward's mission?

Lifeward's mission is to innovate and transform lives for those with physical limitations.

Last updated: May 7, 2025